Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 22, 2016
A headlight on liquid biopsies: a challenging tool for breast cancer managementDaniela Massihnia, Alessandro Perez, Viviana Bazan, et al.Expert Opinion on Drug Safety|December 16, 2014
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapyGiuseppe Bronte, Enrico Bronte, Giuseppina Novo, et al.Therapeutic Advances in Medical Oncology|August 28, 2020
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI scoreAntonio Galvano, Marta Peri, Aurelia Ada Guarini, et al.Breast Cancer Research and Treatment|January 30, 2008
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?Antonio Russo, Valentina Calò, Loredana Bruno, et al.Cancers|March 1, 2020
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-AnalysisAntonio Galvano, Marta Castiglia, Sergio Rizzo, et al.Cancers|August 25, 2019
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-AnalysisAntonio Galvano, Lorena Incorvaia, Giuseppe Badalamenti, et al.Transfusion|June 26, 2010
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximabDomenica Caramazza, Gerlando Quintini, Ignazio Abbene, et al.Oncology|December 17, 2013
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant settingDaniele Santini, Alice Zoccoli, Chiara Gregorj, et al.Journal of Bone Oncology|August 24, 2019
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trialsAntonio Galvano, Dalila Scaturro, Giuseppe Badalamenti, et al.Journal of Cellular Physiology|June 17, 2011
PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapyBruno Vincenzi, Daniele Santini, Gaia Schiavon, et al.Pageof 7